Phoenix Financial Statements From 2010 to 2024
| PBAXUDelisted Stock | USD 10.87 0.00 0.00% |
Check Phoenix Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phoenix Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Phoenix financial statements analysis is a perfect complement when working with Phoenix Biotech Valuation or Volatility modules.
Phoenix |
Phoenix Biotech Acquisition Company Return On Asset Analysis
Phoenix Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Phoenix Biotech Return On Asset | -0.0255 |
Most of Phoenix Biotech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phoenix Biotech Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Phoenix Biotech Acquisition has a Return On Asset of -0.0255. This is 94.57% lower than that of the Capital Markets sector and significantly lower than that of the Financials industry. The return on asset for all United States stocks is 81.79% lower than that of the firm.
Phoenix Biotech Acqu Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Phoenix Biotech's current stock value. Our valuation model uses many indicators to compare Phoenix Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phoenix Biotech competition to find correlations between indicators driving Phoenix Biotech's intrinsic value. More Info.Phoenix Biotech Acquisition is regarded fourth in return on asset category among its peers. It is regarded fifth in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Phoenix Biotech by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Phoenix Biotech Financial Statements
Phoenix Biotech shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Phoenix Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Phoenix Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Phoenix Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Phoenix Biotech Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in Oakland, California. Phoenix Biotech is traded on NASDAQ Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Phoenix Stock
If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |